← Leaderboards
Akos Nyerges
Harvard Medical School
$237,214
Attributed
$237,214
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $120.5K · FY2023–24$200K$150K$100K$50K$0
'23
'24
Funding mix
By agency
NIH$237,214 · 1
By mechanism
K99$237,214 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- John J Mekalanos$34,471,043
- Christopher S Chen$23,331,537
- Karthik Hullahalli$110,751
- Joshua James Ziarek$5,354,565
Others in their field
Other Rising Stars on “Advisory Committees”
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Johanna Marizan-Ho · Palantir Technologies, Inc.$9,612,691
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Brian Todd Schaneberg · Illinois Institute Of Technology$6,784,113
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Christine O'Connell · H. Lee Moffitt Cancer Ctr & Res Inst$5,494,823
Research focus
Advisory CommitteesAmino AcidsAmino Acyl-Trna SynthetasesAmmoniaAnimal ModelAutoimmune DiseasesBacteriaBacterial ResistanceBacteriophagesBiological ProductsCareer DevelopmentCell GrowthCell ProliferationCellsCell SurvivalChurchClinical TranslationCodeCodon NucleotidesColonization ResistanceDevelopment PlansDoseDrug Delivery SystemsAddiction
Grant awards (2)
Development of a Gene-Transfer-Resistant and Biocontained Next-Generation Bacterial Host for Controlled Drug Delivery$120,498
K99 · FY2024 · EB · contact PI
Development of a Gene-Transfer-Resistant and Biocontained Next-Generation Bacterial Host for Controlled Drug Delivery$116,716
K99 · FY2023 · EB · contact PI